Expression of FasL gene in T cells of renal allograft recipients

Immunol Lett. 2002 Jan 1;80(1):9-13. doi: 10.1016/s0165-2478(01)00299-1.

Abstract

FasL molecule expressed on activated T cells induces apoptosis in Fas-expressing cells. It is possible that apoptosis induced by FasL is involved in the process of allograft destruction brought about by infiltrating T cells. The aim of our study was to evaluate expression of FasL gene in peripheral blood T cells of renal allograft recipients (RAR). We have studied 25 patients: 16 with uneventful stable course (RAR-S) and nine during biopsy proven chronic rejection (RAR-CH). The relative expression of FasL mRNA compared with that of beta-actin was established by semi-quantitative RT-PCR. We have found that FasL gene expression was significantly increased in T cells of RAR-CH compared to RAR-S (P<0.01). Our results suggest that T cell expression of FasL gene is increased during chronic rejection. Therefore, this phenomenon may pay a role in allograft injury associated with that process. Further studies are needed to unravel possible clinical consequences of observed differences in T cell expression of FasL.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apoptosis
  • Azathioprine / therapeutic use
  • Cyclosporine / therapeutic use
  • Fas Ligand Protein
  • Gene Expression Regulation*
  • Graft Rejection / drug therapy
  • Graft Rejection / immunology*
  • Graft Rejection / prevention & control
  • Humans
  • Kidney Transplantation / immunology*
  • Membrane Glycoproteins / genetics*
  • Membrane Glycoproteins / physiology
  • Middle Aged
  • Prednisone / therapeutic use
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • T-Lymphocytes / cytology
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism*

Substances

  • FASLG protein, human
  • Fas Ligand Protein
  • Membrane Glycoproteins
  • RNA, Messenger
  • Cyclosporine
  • Azathioprine
  • Prednisone